Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease.

@article{Yuen1997ComparisonBC,
  title={Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease.},
  author={A. Yuen and S. Rosenberg and R. Hoppe and J. Halpern and S. Horning},
  journal={Blood},
  year={1997},
  volume={89 3},
  pages={
          814-22
        }
}
  • A. Yuen, S. Rosenberg, +2 authors S. Horning
  • Published 1997
  • Medicine
  • Blood
  • Sixty patients with Hodgkin's disease, refractory to or at first recurrence after chemotherapy, received cytoreductive therapy followed by high-dose etoposide, cyclophosphamide and either total body irradiation or carmustine and autografting (median follow-up, 3.6 years; range, 1.1 to 7.5 years). A matched conventional salvage group of 103 patients was selected from patients treated at Stanford University Medical Center between January 1976 and January 1989 (median follow-up, 10.3 years; range… CONTINUE READING
    222 Citations
    Conventional salvage chemotherapy vs. high-dose therapy with autografting for recurrent or refractory Hodgkin's disease patients
    • 18
    • Highly Influenced
    Long-term follow-up of salvage radiotherapy in Hodgkin's lymphoma after chemotherapy failure.
    • 20
    High-dose therapy and autologous hematopoietic stem-cell transplantation for recurrent or refractory pediatric Hodgkin's disease: results and prognostic indices.
    • 68
    High‐dose therapy for Hodgkin's disease
    • 15

    References

    SHOWING 1-10 OF 37 REFERENCES
    Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease.
    • 235
    Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease.
    • 103
    MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease.
    • P. Klimo, J. Connors
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 1985
    • 154
    Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma.
    • 91
    High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease.
    • 182
    Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease.
    • 175